(PHILADELPHIA) – Combining natural organic atoms with metal complexes, scientists at The Wistar Institute have developed a new type of enzyme inhibitor capable of blocking a biochemical pathway that ...
Molecular Tumor Board–Assisted Care in an Advanced Cancer Population: Results of a Phase II Clinical Trial The development of the selective RET inhibitors selpercatinib and pralsetinib has ...
An effective treatment could be found for one of the most aggressive pediatric cancers, alveolar rhabdomyosarcoma (aRMS). These kinds of tumors, which develop mainly in skeletal muscle, are ...
In a new study published in Science Signaling titled, “Restoration of striatal neuroprotective pathways by kinase inhibitor treatment of Parkinson’s linked-LRRK2 mutant mice,” researchers from ...
THERE IS CURRENTLY NO CURE TO AN HIV INFECTION. HOWEVER, RESEARCHERS AT JOHNS HOPKINS MEDICINE HAVE DISCOVERED AN ENZYME THAT PLAYS A KEY ROLE IN REPLICATING HIV. OUR MINDY BASARA HAS BEEN FOLLOWING ...
Findings from the LEAP2MONO study support the regulatory submission of venglustat for treatment of type 3 Gaucher disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results